Ruggiero Corcella
Ruggiero Corcella is a journalist and writer known for his insightful coverage of health and social issues, particularly focusing on rare diseases and the challenges faced by families dealing with such conditions. His recent article highlights the emotional and logistical journey families undertake to seek appropriate medical care for children with rare neurological disorders, reflecting on the complexities of diagnosis, support, and the healthcare system.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 3 | 6.33 | 0.17% | +0% | 60,461,826 | 104,304 | $2,000,000 | 3,450$ |
| Totals | 3 | 60,461,826 | 104,304 | $2,000,000 | 3,450$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Ruggiero Corcella is the author of the article discussing the use of AI in identifying cognitive profiles of Parkinson's disease.
7
Italy:
Ruggiero Corcella is the author of the article discussing the West Nile virus.
7
Italy:
Ruggiero Corcella is the author of the article discussing the EuReCa-THREE study on cardiac arrest response times in Europe.
5
Italy:
Ruggiero Corcella is the journalist who wrote the article discussing neurotechnology and ethical recommendations by UNESCO.
5
Italy:
Ruggiero Corcella is the author of the article discussing the groundbreaking case of Andrea S.
5
Italy:
Ruggiero Corcella is the author of the article discussing the challenges faced by patients with hypophosphatasia.
5
Italy:
Ruggiero Corcella is the author of the article discussing the National Day of Relief in Italy.
5
Italy:
Ruggiero Corcella is the author of the article discussing the use of generative artificial intelligence in healthcare.
7
Italy:
Ruggiero Corcella recounts the human and scientific story of Robert Gallo.
6
Italy:
Ruggiero Corcella is the journalist reporting on the FDA's approval of the first clinical study for pig liver transplants in humans.
7